These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 338006

  • 21. Synthetic and genetically engineered allergen derivatives for specific immunotherapy of type I allergy.
    Valenta R, Vrtala S, Focke-Tejkl M, Twardosz A, Swoboda I, Bugajska-Schretter A, Spitzauer S, Kraft D.
    Clin Allergy Immunol; 2002; 16():495-517. PubMed ID: 11577556
    [No Abstract] [Full Text] [Related]

  • 22. [Immunologic desensitization].
    Valovirta E.
    Duodecim; 1998; 114(17):1739-46. PubMed ID: 11717782
    [No Abstract] [Full Text] [Related]

  • 23. [Bacterial allergy in patients with chronic cholecystitis and the effectiveness of specific hyposensitization].
    Nogaller AM, Smirnova SI, Alatyrtseva IE, Avtonomova AS, Larkin RM.
    Sov Med; 1973 Nov; 36(11):42-6. PubMed ID: 4787429
    [No Abstract] [Full Text] [Related]

  • 24. [New concepts in therapy of type I allergic diseases].
    Valenta R, Steinberger P, Vrtala S, Grote M, Laffer S, Sperr WR, Valent P, Kraft D, Scheiner O.
    Wien Klin Wochenschr; 1993 Nov; 105(23):682-6. PubMed ID: 7508663
    [Abstract] [Full Text] [Related]

  • 25. Broad perspectives of allergen specific immunotherapy.
    Thomas WR.
    Hum Vaccin Immunother; 2017 Oct 03; 13(10):2385-2389. PubMed ID: 28933669
    [No Abstract] [Full Text] [Related]

  • 26. Mithridates VI Eupator of Pontus and mithridatism.
    Valle G, Carmignani M, Stanislao M, Facciorusso A, Volpe AR.
    Allergy; 2012 Jan 03; 67(1):138-9; author reply 139-40. PubMed ID: 21899559
    [No Abstract] [Full Text] [Related]

  • 27. [Rapid hyposensitization].
    Krankenpfl J; 2004 Jan 03; 42(1-2):24-5. PubMed ID: 15116774
    [No Abstract] [Full Text] [Related]

  • 28. Intravaginal desensitization to seminal fluid.
    Nusam D, Geva A, Kalderon I, Cohen S.
    Allergy; 1999 Jul 03; 54(7):765. PubMed ID: 10442537
    [No Abstract] [Full Text] [Related]

  • 29. [Hyposensitization].
    Canseco González C.
    Alergia; 1983 Apr 03; 30(2):77-88. PubMed ID: 6638411
    [No Abstract] [Full Text] [Related]

  • 30. [Rush desensitization to drugs: elements for protocol rationalization].
    Moneret-Vautrin DA, Kanny G, Beaudouin E.
    Allerg Immunol (Paris); 1999 Mar 03; 31(3):73-8. PubMed ID: 10226680
    [Abstract] [Full Text] [Related]

  • 31. Hyposensitization: assessment of results [proceedings].
    Citron KM.
    Br J Dis Chest; 1977 Oct 03; 71(4):241-2. PubMed ID: 338007
    [No Abstract] [Full Text] [Related]

  • 32. Modifying allergens and using adjuvants for specific immunotherapy.
    Larché M, Ferreira F, Mohapatra SS.
    Clin Allergy Immunol; 2004 Oct 03; 18():641-61. PubMed ID: 15042940
    [No Abstract] [Full Text] [Related]

  • 33. [Clinical aspects, diagnosis and therapy of allergic reactions].
    Fuchs E.
    Ric Clin Lab; 1983 Oct 03; 13 Suppl 2():57-66. PubMed ID: 6142520
    [No Abstract] [Full Text] [Related]

  • 34. [The treatment of atopic rhinitis in children with an accelerated variant of specific immunotherapy].
    Gamzatova AA, Gadzhimirzaev GA.
    Vestn Otorinolaringol; 1994 Oct 03; (5-6):33-7. PubMed ID: 7856017
    [Abstract] [Full Text] [Related]

  • 35. Allergy vaccination with peptides--SIT with major cat allergen Fel d 1 peptides: safety, tolerability and dose responses.
    Worm M.
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009 Oct 03; 96():349-53; discussion 353-4. PubMed ID: 20799479
    [No Abstract] [Full Text] [Related]

  • 36. Practical use of allergenic molecules.
    Asero R.
    Eur Ann Allergy Clin Immunol; 2006 Sep 03; 38(7):218-9. PubMed ID: 17124775
    [No Abstract] [Full Text] [Related]

  • 37. [Inhalation allergy of the immediate type (type I)].
    Fuchs E.
    Internist (Berl); 1986 Jun 03; 27(6):344-52. PubMed ID: 2427470
    [No Abstract] [Full Text] [Related]

  • 38. Allergic reactions to pets.
    Med Lett Drugs Ther; 1974 Apr 12; 16(8):35-6. PubMed ID: 4856626
    [No Abstract] [Full Text] [Related]

  • 39. Toll-like receptors as targets for enhancing the efficacy of immunotherapy.
    Mutschlechner S, Deifl S, Bohle B.
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009 Apr 12; 96():296-301; discussion 301-2. PubMed ID: 20799474
    [No Abstract] [Full Text] [Related]

  • 40. [Hyposensitization therapy with delayed-absorption antigens in asthmatic children. Evaluation of results].
    Businco E, Frediani T, Lucarelli S, Ruberto U, Barbato MB, Businco L.
    Minerva Pediatr; 1976 Dec 29; 28(40):2507-10. PubMed ID: 1012254
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.